Interim Results Of Prospective Pilot Phase Ii Trial Of Concurrent Anti-Pd-1 And Stereotactic Radiosurgery (Srs) For Melanoma And Nsclc Patients With Brain Metastases (Nct02858869).

Mohammad Khurram Khan,Tahseen Nasti,Melinda Lynne Yushak,David H. Lawson,Jeffrey M. Switchenko,David Wallington,Troy Kleber,Khadija Kirmani,Taofeek Kunle Owonikoko,Suresh S. Ramalingam,Rafi Ahmed

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 3|浏览48

暂无评分

摘要

e22002Background: The safety and efficacy of concurrent radiotherapy (SRS) and single agent (anti-PD-1) checkpoint inhibitor have not been established. We report the first results of an interim ana...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要